Drugs / Hypozalix
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02854358 Comparator | Mar 2015 → Feb 2016 | head and neck cancer | Shiraz University of Medical Sciences | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypozalix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02854358 ↗ |